Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Sedatives and Hypnotics Drugs: Benzodiazepines

Sedatives and Hypnotics Drugs: Benzodiazepines

Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...

Anxiolytic Drugs: Benzodiazepines and Buspirone

Anxiolytic Drugs: Benzodiazepines and Buspirone

Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...

CNS Depressants: Barbiturates and Benzodiazepines

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...

CNS Depressants: Alcohol and Nicotine

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

Anxiolytic Drugs: Overview

Anxiolytic Drugs: Overview

Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic circuitry.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Assessing the trustworthiness of health guidelines recommendations: the transparent, rigorous, useable, standardized, and trustworthy guide (TRUSTGUIDES) tools development.

Journal of clinical epidemiology·2026

Same author

MediLabSecure: A decade of One Health actions to prevent emerging vector-borne diseases in the Mediterranean, Sahel and Black Sea regions.

One health (Amsterdam, Netherlands)·2026

Same author

Short-term effects of PM10 on cause-specific mortality in municipalities across industrial sites in Italy.

Epidemiologia e prevenzione·2026

Same author

Recommendations for the use of off-label rituximab for the treatment of multiple sclerosis in low-resource settings.

Multiple sclerosis and related disorders·2025

Same author

Frequent Users of Emergency Departments: Analysis of the Characteristics and Geographical Distribution in a Local Health Authority in Rome, Italy.

Healthcare (Basel, Switzerland)·2025

Same author

More is more? The role of surgeon in the volume-outcome relationship: an Italian population-based cohort study.

BMJ open·2025

Search research articles

Related Experiment Video

Updated: Jun 15, 2026

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

Benzodiazepines for alcohol withdrawal.

Laura Amato¹, Silvia Minozzi, Simona Vecchi

¹Department of Epidemiology, ASL RM/E, Via di Santa Costanza, 53, Rome, Italy, 00198.

The Cochrane Database of Systematic Reviews

|March 19, 2010

Summary

Benzodiazepines show benefits for alcohol withdrawal symptoms, especially seizures, compared to placebo. However, study variations limit definitive conclusions on their overall effectiveness and safety.

More Related Videos

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development

Published on: July 13, 2014

A Novel Method of Drug Administration to Multiple Zebrafish (Danio rerio) and the Quantification of Withdrawal

A Novel Method of Drug Administration to Multiple Zebrafish (Danio rerio) and the Quantification of Withdrawal

Published on: November 12, 2014

Related Experiment Videos

Last Updated: Jun 15, 2026

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development

Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development

Published on: July 13, 2014

A Novel Method of Drug Administration to Multiple Zebrafish (Danio rerio) and the Quantification of Withdrawal

A Novel Method of Drug Administration to Multiple Zebrafish (Danio rerio) and the Quantification of Withdrawal

Published on: November 12, 2014

Area of Science:

Pharmacology
Addiction Medicine
Clinical Trials

Background:

Alcohol abuse and dependence is a global health issue.
Benzodiazepines are commonly used to manage alcohol withdrawal symptoms.
The comparative efficacy of different benzodiazepines and administration regimens remains unclear.

Purpose of the Study:

To evaluate the effectiveness and safety of benzodiazepines in treating alcohol withdrawal.
To compare benzodiazepines against placebo and other pharmacological treatments.
To assess different benzodiazepine types and administration schedules.

Main Methods:

Systematic review of randomized controlled trials (RCTs) from multiple databases (PubMed, EMBASE, CINAHL, EconLIT) up to December 2009.
Included RCTs comparing benzodiazepines with placebo, other drugs, or each other, regardless of patient demographics or treatment setting.
Data extraction and screening performed independently by two authors.

Main Results:

Benzodiazepines were more effective than placebo in reducing seizures (RR 0.16).
A trend favored benzodiazepines for seizure and delirium control versus other drugs, though statistical significance was limited.
Chlordiazepoxide showed a trend towards better outcomes than other benzodiazepines, but results were not statistically significant.

Conclusions:

Benzodiazepines demonstrate a protective effect against alcohol withdrawal symptoms, particularly seizures, when compared to placebo.
A potential benefit exists when comparing benzodiazepines to other drugs for various withdrawal outcomes.
Heterogeneity in trial interventions and outcome assessments prevents definitive conclusions on benzodiazepine effectiveness and safety.